Context Low-risk differentiated thyroid cancer (DTC) is overdiagnosed, but true incidence
has increased as well. Owing to its excellent prognosis with low morbidity and mortality …

Each year, the proportion of thyroid cancer patients presenting with low-risk disease is
increasing. The shift in the landscape of thyroid cancer presentation is forcing clinicians to re …

Controversy exists over optimal management of low-risk differentiated thyroid cancer. This
controversy occurs in all aspects of management, including surgery, use of radioactive …

Introduction: In the past, total thyroidectomy was usually recommended as the initial
therapeutic approach in all but the lowest risk differentiated thyroid cancers. Today, many …

Context Modern management of differentiated thyroid cancer requires individualized care
plans that tailor the intensity of therapy and follow-up to the estimated risks of recurrence …

Differentiated thyroid carcinoma (DTC) is the most common endocrine cancer. Particularly
the incidence of small clinically indolent tumors has been increasing significantly during the …

Considerable changes have occurred in the management of differentiated thyroid cancer
(DTC) during the past four decades, based on improved knowledge of the biology of DTC …

The treatment paradigm for thyroid cancer has shifted from a one-size-fits-all approach to
more personalized protocols that range from active surveillance to total thyroidectomy …

Background: Due to the excellent prognosis and relatively high incidence of small low-risk
thyroid cancers, more conservative management strategies such as active surveillance (AS) …

Active Surveillance is a non-invasive strategy designed to identify a minority of patients with
low-risk papillary thyroid carcinoma who might experience clinical progression and benefit …